Upload Avatar (500 x 500)
Xiaolie He
Life Science
Tongji University
Shanghai
Language: Chinese, English
Biomaterials
Stem Cells
Fate Regulation
Spinal Cord
Injury Repair
Neural Regeneration
Cell Therapy
Tissue Engineering
Molecular Mechanisms
Therapeutic Interventions
Areas of Focus
- Biomaterials and stem cell fate regulation
- Spinal cord injury repair and neural regeneration mechanisms
Work Experience
- 2020-09 - Present: Postdoctoral Researcher, Tongji University, Key Laboratory of Spinal Cord Injury Regeneration and Repair, Ministry of Education
- 2023-10 - Present: Assistant Professor, Tongji University, School of Life Science and Technology
Academic Background & Achievements
- Bachelor: Nanjing Normal University, School of Life Sciences
- Master & PhD: Tongji University, School of Life Science and Technology, Supervisor: Professor Rongrong Zhu
- Postdoctoral Researcher: Tongji University, Key Laboratory of Spinal Cord Injury Regeneration and Repair, Ministry of Education, Collaborative Supervisor: Professor Liming Cheng
- Hosted several national and postdoctoral science fund projects
Publications
- Spinal cord injury: molecular mechanisms and therapeutic interventions, Xiaolie He et al., 2023
- Combination therapy with ultrasound and 2D nanomaterials promotes recovery after spinal cord injury via Piezo1 downregulation, Xiaolie He et al., 2023
- Bioactive 2D nanomaterials for neural repair and regeneration, Xiaolie He et al., 2022
- Biocompatible exosome-modified fibrin gel accelerates the recovery of spinal cord injury by VGF-mediated oligodendrogenesis, Xiaolie He et al., 2022
- MgFe-LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self-Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells, Xiaolie He et al., 2021
- Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder, Xiaolie He et al., 2021
- Activation of CB2R with AM1241 ameliorates neurodegeneration via the Xist/miR-133b-3p/Pitx3 axis, Xiaolie He et al., 2020
- Targeting the Endocannabinoid/CB1 Receptor System for Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles, Xiaolie He et al., 2017
- Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression, Xiaolie He et al., 2016
